Clinical Trials Directory

Trials / Completed

CompletedNCT05325918

HIF-1 Alpha, VEGF and MMP-8 Levels in PICF of Smokers Versus Non Smokers

HIF-1 Alpha, VEGF and MMP-8 Levels in Peri-implant Crevicular Fluid of Smokers Versus Non Smokers

Status
Completed
Phase
Study type
Observational
Enrollment
14 (actual)
Sponsor
Future University in Egypt · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Smoking is a major risk factor for developing peri-implantitis so the current study is comparing inflammatory markers in smokers versus non smokers to know if they have a potential role in pathogenesis of peri-implantitis

Detailed description

Peri -implant crevicular fluid was obtained from seven smoker patients and then compared to peri-implant crevicular fluid from seven non smoker individuals. The peri-implant crevicular fluid was obtained using periopaper strips then analyzed using ELISA kits of these markers; HIF-1 Alpha, VEGF and MMP-8

Conditions

Timeline

Start date
2021-08-29
Primary completion
2022-01-15
Completion
2022-01-30
First posted
2022-04-13
Last updated
2022-04-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05325918. Inclusion in this directory is not an endorsement.